Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
Price:
23.92
HKD
-1.16%
Market Closed
Market Cap:
HK$8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Zylox-Tonbridge Medical Technology Co Ltd
HKEX:2190
|
CN |
Balance Sheet
Balance Sheet Decomposition
Zylox-Tonbridge Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Balance Sheet Decomposition is not available for
Zylox-Tonbridge Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Balance Sheet
Zylox-Tonbridge Medical Technology Co Ltd
Zylox-Tonbridge Medical Technology Co Ltd
Currency: CNY
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Cash Equivalents |
46
|
60
|
1 418
|
1 205
|
|
| Cash |
46
|
60
|
1 418
|
1 205
|
|
| Short-Term Investments |
52
|
258
|
1 511
|
655
|
|
| Total Receivables |
9
|
7
|
5
|
12
|
|
| Accounts Receivables |
1
|
0
|
0
|
1
|
|
| Other Receivables |
8
|
6
|
5
|
11
|
|
| Inventory |
10
|
29
|
57
|
119
|
|
| Other Current Assets |
8
|
17
|
33
|
70
|
|
| Total Current Assets |
125
|
370
|
3 024
|
2 063
|
|
| PP&E Net |
71
|
122
|
212
|
338
|
|
| PP&E Gross |
71
|
122
|
212
|
338
|
|
| Accumulated Depreciation |
19
|
23
|
30
|
47
|
|
| Intangible Assets |
10
|
8
|
5
|
10
|
|
| Long-Term Investments |
0
|
0
|
0
|
832
|
|
| Other Long-Term Assets |
1
|
4
|
7
|
11
|
|
| Total Assets |
207
N/A
|
504
+143%
|
3 248
+545%
|
3 254
+0%
|
|
| Liabilities | |||||
| Accounts Payable |
2
|
5
|
14
|
11
|
|
| Accrued Liabilities |
8
|
19
|
42
|
70
|
|
| Short-Term Debt |
13
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
7
|
3
|
7
|
|
| Other Current Liabilities |
8
|
21
|
38
|
65
|
|
| Total Current Liabilities |
33
|
52
|
97
|
152
|
|
| Long-Term Debt |
8
|
28
|
7
|
7
|
|
| Total Liabilities |
41
N/A
|
79
+92%
|
104
+31%
|
160
+54%
|
|
| Equity | |||||
| Common Stock |
183
|
225
|
332
|
332
|
|
| Retained Earnings |
62
|
155
|
506
|
480
|
|
| Additional Paid In Capital |
0
|
0
|
2 270
|
2 270
|
|
| Treasury Stock |
0
|
0
|
9
|
34
|
|
| Other Equity |
85
|
108
|
184
|
45
|
|
| Total Equity |
166
N/A
|
425
+156%
|
3 145
+640%
|
3 094
-2%
|
|
| Total Liabilities & Equity |
207
N/A
|
504
+143%
|
3 248
+545%
|
3 254
+0%
|
|
| Shares Outstanding | |||||
| Common Shares Outstanding |
332
|
332
|
332
|
330
|
|
Switch to:
Switch to:
See Also
Discover More
